Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis.
primary studies published RCT
Details- 2017
- Bieli C
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.
primary studies published RCT
Details- 2017
- Bruzzese E
Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
primary studies published RCT
Details- 2017
- De Boeck K
Effect of synbiotic supplementation in children and adolescents with cystic fibrosis: a randomized controlled clinical trial.
primary studies published RCT
Details- 2017
- de Freitas MB
Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.
primary studies published RCT
Details- 2017
- Donaldson SH
Effects of treadmill exercise versus Flutter(R) on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial.
primary studies published RCT
Details- 2017
- Dwyer TJ
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
primary studies published RCT
Details- 2017
- Greenwood J
Chest physiotherapy can affect the lung clearance index in cystic fibrosis patients.
primary studies published RCT
Details- 2017
- Grosse-Onnebrink J
Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial.
primary studies published RCT
Details- 2017
- Kanhere M
Improvement in exercise duration, lung function and well-being in G551D-Cystic Fibrosis patients: a double-blind, placebo-controlled, randomised, cross-over study with ivacaftor.
primary studies published RCT
Details- 2017
- Keating DT